These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33739398)

  • 1. Evolution of biophysical tools for quantitative protein interactions and drug discovery.
    Harish M; Venkatraman P
    Emerg Top Life Sci; 2021 May; 5(1):1-12. PubMed ID: 33739398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biophysical Analysis of the Protein-Small Molecule Interactions to Develop Small Molecule Drug Discovery].
    Nagatoishi S; Caaveiro JMM; Tsumoto K
    Yakugaku Zasshi; 2018; 138(8):1033-1041. PubMed ID: 30068844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-Small Molecule Interactions in Native Mass Spectrometry.
    Bennett JL; Nguyen GTH; Donald WA
    Chem Rev; 2022 Apr; 122(8):7327-7385. PubMed ID: 34449207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interactions: principles, techniques, and their potential role in new drug development.
    Khan SH; Ahmad F; Ahmad N; Flynn DC; Kumar R
    J Biomol Struct Dyn; 2011 Jun; 28(6):929-38. PubMed ID: 21469753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical methods in drug discovery from small molecule to pharmaceutical.
    Holdgate G; Geschwindner S; Breeze A; Davies G; Colclough N; Temesi D; Ward L
    Methods Mol Biol; 2013; 1008():327-55. PubMed ID: 23729258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Contributions of Conformational Changes, Thermodynamics, and Kinetics of RNA-Small Molecule Interactions.
    Umuhire Juru A; Patwardhan NN; Hargrove AE
    ACS Chem Biol; 2019 May; 14(5):824-838. PubMed ID: 31042354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative biophysical characterization of intrinsically disordered proteins.
    Gibbs EB; Showalter SA
    Biochemistry; 2015 Feb; 54(6):1314-26. PubMed ID: 25631161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Interaction Domains and Post-Translational Modifications: Structural Features and Drug Discovery Applications.
    Vincenzi M; Mercurio FA; Leone M
    Curr Med Chem; 2020; 27(37):6306-6355. PubMed ID: 31250750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical Models of Protein Evolution: Understanding the Patterns of Evolutionary Sequence Divergence.
    Echave J; Wilke CO
    Annu Rev Biophys; 2017 May; 46():85-103. PubMed ID: 28301766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence evolution and the mechanism of protein folding.
    Ortiz AR; Skolnick J
    Biophys J; 2000 Oct; 79(4):1787-99. PubMed ID: 11023886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.
    Winter A; Higueruelo AP; Marsh M; Sigurdardottir A; Pitt WR; Blundell TL
    Q Rev Biophys; 2012 Nov; 45(4):383-426. PubMed ID: 22971516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical methods for identifying fragment-based inhibitors of protein-protein interactions.
    Pfaff SJ; Chimenti MS; Kelly MJ; Arkin MR
    Methods Mol Biol; 2015; 1278():587-613. PubMed ID: 25859978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of computational chemistry and biophysical techniques to fragment-based drug discovery.
    Gozalbes R; Carbajo RJ; Pineda-Lucena A
    Curr Med Chem; 2010; 17(17):1769-94. PubMed ID: 20345344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid State Concerns During Drug Discovery and Development: Thermodynamic and Kinetic Aspects of Crystal Polymorphism and the Special Cases of Concomitant Polymorphs, Co-Crystals and Glasses.
    Otto DP; De Villiers MM
    Curr Drug Discov Technol; 2017; 14(2):72-105. PubMed ID: 27908255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel High-Throughput FLIPR Tetra-Based Method for Capturing Highly Confluent Kinetic Data for Structure-Kinetic Relationship Guided Early Drug Discovery.
    Khurana P; McWilliams L; Wingfield J; Barratt D; Srinivasan B
    SLAS Discov; 2021 Jun; 26(5):684-697. PubMed ID: 33783249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA sequence elements required for high affinity binding by the zinc finger domain of tristetraprolin: conformational changes coupled to the bipartite nature of Au-rich MRNA-destabilizing motifs.
    Brewer BY; Malicka J; Blackshear PJ; Wilson GM
    J Biol Chem; 2004 Jul; 279(27):27870-7. PubMed ID: 15117938
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.